UBS ONCOLOGY IMPACT FUND
Similar Organizations
Barton Capital
Barton Capital
Blue Marlin AB
Blue Marlin AB
Edreams Factory
Edreams Factory
narval
narval
oncology impact fund
oncology impact fund
Overland Tandberg
Overland Tandberg
Sysmax
Sysmax
The NSB Group
The NSB Group
TTM Holding
TTM Holding
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-09-04 | Repare Therapeutics | UBS Oncology Impact Fund investment in Series B - Repare Therapeutics | 82.5 M USD |
| 2019-08-21 | Oncorus | UBS Oncology Impact Fund investment in Series B - Oncorus | 79.5 M USD |
| 2019-05-13 | ElevateBio | UBS Oncology Impact Fund investment in Series A - ElevateBio | 150 M USD |
| 2017-10-03 | Cullinan Therapeutics | UBS Oncology Impact Fund investment in Series A - Cullinan Therapeutics | 150 M USD |
| 2017-06-22 | Repare Therapeutics | UBS Oncology Impact Fund investment in Series A - Repare Therapeutics | 68 M USD |
More informations about "UBS Oncology Impact Fund"
UBS Impact Investing - Crossing the Valley | UBS Global
Sep 19, 2023 The American Cancer Society estimates 21.6 million new cases of cancer annually by 2030, compared to about 14 million in 2012. ... The UBS Oncology Impact Fund model was able to deliver successful performance quite quickly. UBS Wealth Management …See details»
UBS clients help transform the biotech industry through the UBS ...
New York 17 Aug 2022, 17:20 CEST UBS in society Media Global. UBS clients help transform the biotech industry ... Orna’s collaboration with Merck is a notable success for the UBS Oncology Impact Fund and BioImpact Capital, the investment manager of the fund. The fund was …See details»
UBS Oncology Impact Fund: Performance - PitchBook
May 15, 2019 UBS Oncology Impact Fund is a 2016 vintage venture capital fund managed by MPM BioImpact and UBS Group. The fund is located in Zurich, Switzerland. The fund targets pharmaceuticals and biotechnology, life science, and oncology sectors.See details»
UBS clients raise $650 mln for biggest yet biotech impact fund
Oct 6, 2021 The Oncology Impact Fund 2, run by biotechnology investment firm MPM Capital, has raised a total of $850 million, including the $650 million obtained from UBS clients.See details»
UBS Hands Over $650 Million to Life Sciences Impact Investment …
The OIF 2 follows the UBS Oncology Impact Fund (OIF 1), which closed in 2016. The two funds combined total more than $1 billion. “We are proud to connect our clients with brilliant scientists around the world who are working hard to alleviate the pain and suffering caused by cancer,” …See details»
UBS raises $471M for a new kind of cancer research fund
Apr 27, 2016 The investment firm announced today that it has raised $471 million for the final closing of the UBS “Oncology Impact Fund”--an investing initiative aimed at developing new cancer treatments.See details»
UBS Pushes Impact Investing Credentials With Oncology Fund
UBS Wealth Management has raised $471 million for the final closing of the UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer treatments. The fund-raising amount is a record, the Swiss bank said. ... It also supports the aims of the "UBS & …See details»
UBS Raises Record $471 Million for Oncology Impact Fund
Zurich/Basel, 27 April 2016 – UBS Wealth Management has raised a record $471 million for the final closing of the UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer treatments. ... It also supports the aims of the UBS & Society program, which seeks to …See details»
UBS raises $471m for cancer research investment fund - Financial …
Apr 27, 2016 UBS said its “oncology impact fund” was the largest such vehicle in the healthcare sector. It would invest in early-stage cancer treatments, allowing investors to potentially profit from ...See details»
Cancer research pioneers receive first grants from UBS Oncology …
Jan 30, 2023 In 2016, the UBS Oncology Impact Fund raised a record USD 471 million 1 in wealth management clients' money outside the US for impact investment opportunities in oncology, identified and managed by Boston bioventure firm MPM Capital. As a result of its …See details»
UBS Oncology Impact Fund
Feb 7, 2018 A joint partnership between UBS, a Swiss wealth management giant, and MPM Capital, a bio-venture fund manager, the UBS Oncology Impact Fund (OIF) is an evergreen fund that specialises in investments in early stage oncology and cancer therapeutics. Oncology is …See details»
Oncology Impact Fund | Monocle
This week we’re exploring UBS’s groundbreaking Oncology Impact Fund, an impact-investing initiative aimed at developing cancer treatments that has raised close to $500m (€440m). We will hear from analysts and experts across UBS – as well as the partner manager of the fund, …See details»
UBS Oncology Impact Fund - Crunchbase
UBS Oncology Impact Fund. Zürich, Zurich, Switzerland; 106,189; Highlights. Investments 5. obfuscated. Exits . ... 997 Number of Organizations • $154.7B Total Funding Amount • 387 Number of Investors. Track . Show More . Unlock even more features with Crunchbase Pro . …See details»
UBS Raises Record $471m for Oncology Impact Fund - Funds Society
UBS Wealth Management which will release its first quarter results this Tuesday and might announce a change in its business, has raised a record $471 million for the final closing of the UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer …See details»
UBS Oncology Impact Fund 2: Performance - PitchBook
Oct 6, 2021 UBS Oncology Impact Fund 2 is a 2020 vintage venture capital fund managed by MPM Capital and UBS Group. The fund is located in Cambridge, Massachusetts. The fund targets investments in the drrug delivery sector and focuses on health related impact investment.See details»
UBS raises record $471m for Oncology impact fund
Aug 12, 2019 Zurich/Basel, 27 April 2016 – UBS Wealth Management has raised a record $471 million for the final closing of the UBS Oncology Impact Fund, an impact investing initiative aimed at developing cancer treatments. Investments will be made in early stage oncology to …See details»
UBS Oncology Impact Fund Announces $2.5M in Gifts | Penta
Apr 16, 2018 The UBS Oncology Impact Fund announced today that it’s giving away US$2.5 million, half to the American Association for Cancer Research, or AACR, and half to the UBS Optimus Foundation Monday ...See details»
UBS Oncology Impact Fund – Investors Database – Unicorn Nest
Summary . The standard case for the fund is to invest in rounds with 6 partakers. Despite the UBS Oncology Impact Fund, startups are often financed by SunStates Fund, Samsara BioCapital, Redmile Group.The meaningful sponsors for the fund in investment in the same round are …See details»
UBS raises record $471m for Oncology impact investing fund
Aug 12, 2019 Singapore, 27 April 2016 – UBS Wealth Management has raised a record $471 million for the final closing of an impact investing fund aimed at developing cancer treatments. Investments will be made in early stage oncology to accelerate the development of new cures.See details»
Candriam Equities L Oncology Impact N EUR Cap - Financial Times
4 days ago The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) in order to respond to one of the serious long-term …See details»